Cargando…

Potential Psychotropic and COVID-19 Drug Interactions: A Comparison of Integrated Evidence From Six Database Programs

Background Drug interactions are a significant issue in mental illnesses and coronavirus disease 2019 (COVID-19) infections. Inconsistency in drug interaction resources makes prescribing challenging for healthcare professionals. To assess the scope, completeness, and consistency of drug-drug interac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shareef, Javedh, Belagodu Sridhar, Sathvik, Thomas, Sabin, Shariff, Atiqulla, Chalasani, Sriharsha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747991/ https://www.ncbi.nlm.nih.gov/pubmed/35028218 http://dx.doi.org/10.7759/cureus.20319

Ejemplares similares

Assessment of the scope, completeness, and consistency of various drug information resources related to COVID-19 medications in pregnancy and lactation
por: Shareef, Javedh, et al.
Publicado: (2023)

Assessment of Perception, Experience, and Information-seeking Behavior of the Public of Ras Al-Khaimah, United Arab Emirates, Toward Usage and Safety of Complementary and Alternative Medicine
por: Sridhar, Sathvik Belagodu, et al.
Publicado: (2017)

Frequency and Predisposing Factors for Drug-Induced Hypoglycemia in Patients with Type-2 Diabetes Mellitus
por: Shariff, Atiqulla, et al.
Publicado: (2019)

Assessing Consistency of Drug-Drug Interaction-Related Information Across Various Drug Information Resources
por: Shariff, Atiqulla, et al.
Publicado: (2021)

Assessment of Nature, Reasons, and Consequences of Self-medication Practice among General Population of Ras Al-Khaimah, UAE
por: Sridhar, Sathvik B, et al.
Publicado: (2018)

Assessment of Potential Drug–Drug Interactions in Hospitalized Cardiac Patients of a Secondary Care Hospital in the United Arab Emirates
por: Khan, Muhammad Zeeshan, et al.
Publicado: (2019)

Monitoring of adverse drug reactions in psychiatry outpatient department of a Secondary Care Hospital of Ras Al Khaimah, UAE
por: Sridhar, Sathvik Belagodu, et al.
Publicado: (2016)

Assessment of potential drug interactions among psychiatric inpatients receiving antipsychotic therapy of a secondary care hospital, United Arab Emirates
por: Aburamadan, Haneen A.R., et al.
Publicado: (2021)

The Effect of Polymers on Drug Release Kinetics in Nanoemulsion In Situ Gel Formulation
por: Vijaya Rani, K. Reeta, et al.
Publicado: (2022)

Assessment of prevalence of hypovitaminosis D in multiethnic population of the United Arab Emirates
por: Sridhar, Sathvik Belagodu, et al.
Publicado: (2016)

Editorial: Safety and side effects of psychotropic medications
por: de Filippis, Renato, et al.
Publicado: (2023)

Synergistic Effects of Psychotropics Leading to Extraordinary Weight Gain
por: Kemp, Allyson J, et al.
Publicado: (2021)

Effect of the COVID-19 pandemic on the psychotropic drug consumption
por: Benistand, Paul, et al.
Publicado: (2022)

The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization
por: Monson, Eric T., et al.
Publicado: (2023)

A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)

Why Psychotropic Drugs Don't Cure Mental Illness—But Should They?
por: Ivanov, Iliyan, et al.
Publicado: (2021)

Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction
por: Chiappini, Stefania, et al.
Publicado: (2021)

Initiating Psychotropic Treatment in a Patient With Alpha-Gal Syndrome
por: Narlesky, Matthew R, et al.
Publicado: (2022)

Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics
por: Reebye, Pratibha N., et al.
Publicado: (2012)

Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients
por: Martinotti, Giovanni, et al.
Publicado: (2020)

Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
por: Hart, Xenia M., et al.
Publicado: (2021)

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
por: Zito, Julie M., et al.
Publicado: (2021)

Management of psychotropic medications in adults with intellectual disability: a scoping review
por: Costello, Ashley, et al.
Publicado: (2022)

Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey
por: Adachi, Naoto, et al.
Publicado: (2023)

Clinical predictors of psychotropic medication prescription in children with ASD of the ELENA cohort
por: Geoffray, Marie-maude, et al.
Publicado: (2023)

Psychotropic Medication and Substance Use during Pregnancy by Women with Severe Mental Illness
por: Brameld, Kate J., et al.
Publicado: (2017)

Syndrome-Based Prescription to Optimize Psychotropics: Are CHROME Criteria a Game Changer?
por: Muñiz, Ruben, et al.
Publicado: (2021)

Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II
por: Chiappini, Stefania, et al.
Publicado: (2022)

Psychological Distress and Use of Psychotropic Drugs Among University Students—the SHoT Study, Norway
por: Bojanić, Ivana, et al.
Publicado: (2021)

A retrospective study of psychotropic drug treatments in bipolar disorder at acute and maintenance episodes
por: Jing, Pan, et al.
Publicado: (2023)

Case series of drug-induced open bite: Extrapyramidal symptoms related to psychotropic medications
por: Watanabe, Motoko, et al.
Publicado: (2023)

Trends in Psychotropic Medication Prescriptions in Urban China From 2013 to 2017: National Population-Based Study
por: Xu, Lu, et al.
Publicado: (2021)

Psychotropic Medication Adherence and Its Associated Factors Among Schizophrenia Patients: Exploring the Consistency of Adherence Scales
por: Ali, Maghzoub M, et al.
Publicado: (2023)

Anxiety and Depression in COVID Survivors - A Cross-Sectional Study Six Months Past the Acute Illness
por: Avula, Vijaya Chandra R, et al.
Publicado: (2023)

Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report
por: Defrancesco, Michaela, et al.
Publicado: (2020)

Editorial: The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms
por: Esposito, Roberto, et al.
Publicado: (2023)

Prescribing Trends in Psychotropic Medications Among Outpatients of a Latin American Healthcare Setting: A Five-Year Retrospective Study
por: Villalobos-Madriz, Jorge A, et al.
Publicado: (2023)

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
por: Delacrétaz, Aurélie, et al.
Publicado: (2018)

Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances
por: Pichini, Simona, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on the General Mental Health in Sweden: No Observed Changes in the Dispensed Amount of Common Psychotropic Medications in the Region of Scania
por: Wolfschlag, Mirjam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tq3qshfepn2iv0i0gi09toivcg